Price Wealth’s GSK GSK Stock Holding History

Price Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$53K	Buy	1,134 +77	+7%	+$3.86K	0.01%	133
2020 Q2	$54K	Hold	1,057	–	–	0.02%	93
2020 Q1	$50K	Hold	1,057	–	–	0.02%	103
2019 Q4	$62K	Hold	1,057	–	–	0.02%	99
2019 Q3	$56K	Hold	1,057	–	–	0.02%	109
2019 Q2	$53K	Hold	1,057	–	–	0.02%	116
2019 Q1	$55K	Hold	1,057	–	–	0.02%	87
2018 Q4	$50K	Hold	1,057	–	–	0.02%	88
2018 Q3	$53K	Hold	1,057	–	–	0.02%	83
2018 Q2	$53K	Buy	1,057 +257	+32%	+$12.9K	0.02%	109
2018 Q1	$39K	Hold	800	–	–	0.02%	88
2017 Q4	$35K	Buy	+800	New	+$37K	0.02%	74

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Price Wealth's GSK Position: Q3 2020 in Review

Price Wealth increased its GSK (GSK) stake by 7.3% in Q3 2020, buying an estimated $3.86K and bringing the position to 1,134 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #133.

Price Wealth first reported a position in GSK in Q4 2017 and has held it in 12 quarters since. The position peaked at $62K in Q4 2019. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

Price Wealth held 1,134 shares of GSK worth $53K as of Q3 2020.
Price Wealth bought 77 GSK shares in Q3 2020, an estimated $3.86K.
GSK made up 0.01% of Price Wealth's portfolio in Q3 2020, its #133 holding.
Price Wealth first reported a position in GSK in Q4 2017 and has held it in 12 quarters since.
Price Wealth's GSK position peaked at $62K in Q4 2019.
826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.